Strattera
Strattera is a neurology medication containing Atomoxetine, available as 10/18/25/40mg tablets.
- Category
- Neurology · Nootropics
- Active ingredient
- Atomoxetine
- Route
- Oral use
- Form
- Capsule, hard
- Strengths
- 10/18/25/40mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Strattera vary by country.
Details
- Conditions
- Attention deficit hyperactivity disorder
- Therapeutic Class
- Selective Norepinephrine Reuptake Inhibitor
- Pharmacological Class
- SNRI
- Minor Side Effects
- nausea, vomiting, decreased appetite, dry mouth
- Moderate Side Effects
- insomnia, tachycardia, palpitations, irritability
- Dosage Forms
- Capsule, hard
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Originator
- Eli Lilly
- Onset Time
- 2–4 weeks
- Duration
- 24 hours
- Storage Instructions
- Store at room temperature in a dry place.
- Drug Interactions
- MAO inhibitors, salbutamol, antihypertensives
- Age Restrictions
- Not recommended for children under 6 years of age.
What you will receive
Strattera is the originator brand name, made by Eli Lilly. We use it here to identify the medicine only; we are not affiliated with Eli Lilly and do not ship the original Strattera.
- You receive a generic equivalent: the same active ingredient (Atomoxetine) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.